Moderna, largest biotech to go public, fails to impress in market debut
December 07, 2018 at 12:08 PM EST
Moderna Inc's shares fell as much as 6 percent in an upsized market debut on Friday, taking a hit from a broader selloff in the U.S. markets spurred by investors fretting over an economic slowdown.